Thomas Appio serves as Executive at Valeant Pharmaceuticals International, Inc., where they oversee executive responsibilities. Since joining the company, Thomas Appio has executed 57 insider transactions totaling $584.1K, demonstrating a bullish approach to their equity position. Their most recent transaction on Mar 7, 2018 involved receiving (via award) 22,162 shares valued at $0.
Thomas Appio currently holds 2,921,111 shares of Valeant Pharmaceuticals International, Inc. (VRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Thomas Appio has been a net buyer of VRX stock. They have purchased $584.1K and sold $0 worth of shares.
Thomas Appio's most recent insider trade was on Mar 7, 2018, when they sold 22,162 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $23.85 |
| Discretionary |
| Jan 8, 2018 | VRX | $30.1K | Payment | 1,264 | $23.85 | Discretionary |
| Aug 18, 2017 | VRX | $80.5K | Payment | 5,687 | $14.15 | Discretionary |
| May 10, 2017 | VRX | $31.8K | Payment | 3,274 | $9.71 | Discretionary |
| Mar 28, 2017 | VRX | $0 | Award | 63,742 | $N/A | Discretionary |
| Jan 6, 2017 | VRX | $0 | Award | 12,287 | $N/A | Discretionary |